Bruce J. Seeley
2018 - CTI BioPharma
In 2018, Bruce J. Seeley earned a total compensation of $1.1M as Executive Vice President, Chief Operating Officer at CTI BioPharma, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,000 |
|---|---|
| Option Awards | $551,082 |
| Salary | $410,000 |
| Other | $8,250 |
| Total | $1,133,332 |
Seeley received $551.1K in option awards, accounting for 49% of the total pay in 2018.
Seeley also received $164K in non-equity incentive plan, $410K in salary and $8.3K in other compensation.
Rankings
In 2018, Bruce J. Seeley's compensation ranked 8,573rd out of 14,244 executives tracked by ExecPay. In other words, Seeley earned more than 39.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,573 out of 14,244 | 40th |
Division Manufacturing | 3,414 out of 5,759 | 41st |
Major group Chemicals And Allied Products | 1,286 out of 2,122 | 39th |
Industry group Drugs | 1,074 out of 1,811 | 41st |
Industry Pharmaceutical Preparations | 837 out of 1,385 | 40th |
Source: SEC filing on April 4, 2019.
Seeley's colleagues
We found three more compensation records of executives who worked with Bruce J. Seeley at CTI BioPharma in 2018.